Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 6
1993 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week schedule.
Planting AS, van der Burg ME, Stoter G, Beranek P, Verweij J. Planting AS, et al. Clin Oncol (R Coll Radiol). 1992 May;4(3):171-3. doi: 10.1016/s0936-6555(05)81081-7. Clin Oncol (R Coll Radiol). 1992. PMID: 1586634
In a Phase I study fosquidone was administered to 23 patients (15 female, 8 male; mean age 53.6 years) with various solid tumours. ...
In a Phase I study fosquidone was administered to 23 patients (15 female, 8 male; mean age 53.6 years) with various solid tumours. .. …
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma.
Kaye SB, Wanders J, Clavel M, Verweij J, Piccart MJ, Smyth JF, Ten Bokkel Huinink WW, Wagener DJ, Judson IR, Cavalli F. Kaye SB, et al. Ann Oncol. 1992 May;3(5):406-8. doi: 10.1093/oxfordjournals.annonc.a058220. Ann Oncol. 1992. PMID: 1616895 Free article. Clinical Trial.
A total of 91 eligible patients with metastatic cancer have been treated in a series of phase II trials of the novel pentacyclic pyrroloquinone, fosquidone. Tumour types were breast (24), ovary (25), head and neck (21) and melanoma (21). ...A total of 12 patients demonstra …
A total of 91 eligible patients with metastatic cancer have been treated in a series of phase II trials of the novel pentacyclic pyrroloquin …
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials Committee.
Kaye SB, Brampton M, Harper P, Smyth J, Kerr DJ, Gore M, Green JA, Gilby E, Crawford SM, Rustin GJ. Kaye SB, et al. Br J Cancer. 1992 Apr;65(4):624-5. doi: 10.1038/bjc.1992.127. Br J Cancer. 1992. PMID: 1314072 Free PMC article.
A total of 61 eligible patients with metastatic cancer have been treated in a series of Phase II trials of the novel pentacyclic pyrroloquinone, fosquidone. Tumour types were colorectal (23), renal (21), and non small cell lung (17). ...A total of nine patients demonstrate …
A total of 61 eligible patients with metastatic cancer have been treated in a series of Phase II trials of the novel pentacyclic pyrroloquin …